✦ LIBER ✦

A 4-year study of the efficacy and tolerability of enzyme replacement therapy with agalsidase alfa in 36 women with Fabry disease

✍ Scribed by Whybra, Catharina; Miebach, Elke; Mengel, Eugen; Gal, Andreas; Baron, Karin; Beck, Michael; Kampmann, Christoph

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

An open-label, switchover trial to asses

✍ Richards, Sarah; Laney, Dawn; Pervaiz, Muhammad A.; Shankar, Suma 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 62 KB

Effects of enzyme replacement therapy wi

✍ F Dehout; A Schwarting; M Beck; A Mehta; R Ricci; U Widmer; on behalf of the FOS 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 46 KB

Safety and Efficacy of Enzyme Replacemen

✍ J. Edmond Wraith; Anna Tylki-Szymanska; Nathalie Guffon; Y. Howard Lien; Michel 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 198 KB

Enzyme replacement therapy with agalsida

✍ A Mehta; M Beck; P Elliott; R Giugliani; A Linhart; G Sunder-Plassmann; R Schiff 📂 Article 📅 2009 🏛 The Lancet 🌐 English ⚖ 253 KB

Enzyme replacement therapy with agalsida

✍ R Parini; M Rigoldi; F Santus; F Furlan; P De Lorenzo; G Valsecchi; D Concolino; 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 139 KB

Enzyme replacement therapy in a patient

✍ Tanaka, Akemi; Takeda, Taisuke; Hoshina, Takao; Fukai, Kazuyoshi; Yamano, Tsunek 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 281 KB